1 / 9

Oral Medications segment dominated the Compounding Pharmacies Market

Get more details @ http://bit.ly/2r9mHZ8 <br>Compounding pharmacies market players include Fresenius Kabi, B. Braun Medical, Fagron, PharMEDium, Cantrell Drug Company, ITC Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy. Companies are consolidating their market position through adoption of strategies such as collaborations and acquisitions.

jueekate
Download Presentation

Oral Medications segment dominated the Compounding Pharmacies Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Compounding Pharmacies Market forecast to hit $12bn by 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Compounding Pharmacies Market: • Compounding Pharmacies Market will hold a valuation of more than USD 12 billion by 2024, with an estimated CAGR of 5% over 2017-2024. • In an era of consequential transformation in the healthcare delivery, compounding pharmacies market is charting a profitable growth curve. • Although a major chunk of pharmacists are involved in drug manufacturing, yet with the advancement of technology compounding has become an integral of pharmacy practice. • The expanding geriatric population base along with increasing customized medication requirements subject to alternative doses, flavor, formulations are stimulating the market dynamics. • The remarkable expansion of compounding pharmacies market is quite evident from its diversified product landscape which includes oral, rectal, inhaler, ophthalmic, topical, and parenteral.

  3. Continued... • Growing individual preference toward consuming medicines in the form of tablets, capsules have significantly propelled the market demand from this domain. • Sedentary lifestyles along with heavy consumption of fat-rich foods have led to a rise of these cardiac diseases, which in a way is stimulating the necessity of compounded medications. • Pertaining to the increasing natality rates along with incapability of the commercial medicines to meet up with the customized pediatric formulation requirements, pediatric application will also register considerable revenue for compounding pharmacies market by 2024. • Compounding pharmacies market is characterized by some of the restraints such as lack of skilled lab personnel, excessive cost of the process, and issues related to its safety standards. • Some of the companies engaged in compounding pharmacies market include B. Braun Medical, PharMEDium, Fresenius Kabi, Village Compounding Pharmacy, and Cantrell Drug Company.

  4. U.S. Compounding Pharmacies Market size, By Product, 2013-2024 (USD Billion)

  5. Table of Content: • Chapter 1 Methodology • 1.1 Methodology • 1.1.1 Initial data exploration • 1.1.2 Statistical model and forecast • 1.1.3 Industry insights and validation • 1.1.4 Market definitions and forecast parameters • 1.2 Data Sources • 1.2.1 Secondary • 1.2.2 Primary • Chapter 2 Executive Summary • 2.1 Compounding pharmacies industry 3600 synopsis, 2013 - 2024 • 2.1.1 Business trends • 2.1.2 Product trends • 2.1.3 Application trends • 2.1.4 Therapeutic area trends • 2.1.5 Regional trends

  6. Table of Content: • Chapter 3 Compounding Pharmacies Industry Insights • 3.1 Industry segmentation • 3.2 Industry size and forecast, 2013 – 2024 • 3.3 Industry ecosystem analysis • 3.3.1 Vendor matrix • 3.3.2 Distribution channel analysis • 3.4 Industry impact forces • 3.4.1 Growth drivers • 3.4.1.1 Increasing geriatric population and improved longevity • 3.4.1.2 Growing acceptance of personalized medicines in U.S. and Europe • 3.4.1.3 Increasing drug shortage, worldwide • 3.4.1.4 Convenience of using compounded drugs • 3.4.1.5 Growing drug failure rate • 3.4.2 Industry pitfalls and challenges • 3.4.2.1 Lack of skilled lab technicians and pharmacists in developed economies • 3.4.2.2High cost of equipment and maintenance of sterile environment

  7. Table of Content: • 3.4.2.3 Changing regulatory specifications • 3.4.2.4 Consumer perception towards compounded drugs • 3.5 Growth potential analysis • 3.6 Regulatory landscape • 3.6.1 U.S. • 3.6.2 Europe • 3.6.3 Australia • 3.7 Reimbursement landscape • 3.7.1 U.S. • 3.7.2 Europe • 3.7.3 Australia • 3.8 Cost analysis of compounded medications • 3.9 Innovative compounding technologies • 3.9.1 Web-based quality management system • 3.9.2 Digital tools • 3.10 Porter’s Analysis • 3.11Competitive Landscape, 2016 • 3.11.1 Business overview • 3.11.2 Strategic Dashboard • 3.12 PESTEL Analysis

  8. Browse Full Market Research Report On Compounding Pharmacies Market @ http://bit.ly/2rRiI1T Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/749https://www.gminsights.com/request-sample/detail/49

  9. Stay In Touch Website: www.gminsights.com Social Media:

More Related